栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/02/21 | 2,169 | 2,253 | 2,167 | 2,240 | +69 | +3.2% | 739,100 |
2020/02/20 | 2,193 | 2,206 | 2,140 | 2,171 | -31 | -1.4% | 718,400 |
2020/02/19 | 2,257 | 2,257 | 2,148 | 2,202 | -56 | -2.5% | 1,168,400 |
2020/02/18 | 2,450 | 2,450 | 2,237 | 2,258 | -227 | -9.1% | 2,426,000 |
2020/02/17 | 2,400 | 2,549 | 2,360 | 2,485 | +227 | +10.1% | 3,376,500 |
2020/02/14 | 2,226 | 2,314 | 2,219 | 2,258 | +43 | +1.9% | 1,167,600 |
2020/02/13 | 2,369 | 2,369 | 2,177 | 2,215 | -157 | -6.6% | 1,683,500 |
2020/02/12 | 2,419 | 2,425 | 2,336 | 2,372 | -52 | -2.1% | 1,126,300 |
2020/02/10 | 2,520 | 2,600 | 2,375 | 2,424 | +104 | +4.5% | 2,497,700 |
2020/02/07 | 2,317 | 2,393 | 2,265 | 2,320 | +42 | +1.8% | 912,100 |
2020/02/06 | 2,346 | 2,354 | 2,252 | 2,278 | -31 | -1.3% | 649,300 |
2020/02/05 | 2,285 | 2,366 | 2,218 | 2,309 | +74 | +3.3% | 1,009,300 |
2020/02/04 | 2,405 | 2,473 | 2,200 | 2,235 | -14 | -0.6% | 2,211,000 |
2020/02/03 | 2,209 | 2,310 | 2,167 | 2,249 | +54 | +2.5% | 1,417,700 |
2020/01/31 | 2,203 | 2,253 | 2,163 | 2,195 | +52 | +2.4% | 664,800 |
2020/01/30 | 2,149 | 2,181 | 2,095 | 2,143 | -45 | -2.1% | 736,500 |
2020/01/29 | 2,287 | 2,292 | 2,089 | 2,188 | -49 | -2.2% | 956,800 |
2020/01/28 | 2,343 | 2,359 | 2,215 | 2,237 | -90 | -3.9% | 481,600 |
2020/01/27 | 2,250 | 2,401 | 2,239 | 2,327 | +85 | +3.8% | 661,500 |
2020/01/24 | 2,272 | 2,272 | 2,184 | 2,242 | -16 | -0.7% | 218,000 |
2020/01/23 | 2,293 | 2,314 | 2,237 | 2,258 | -46 | -2% | 328,700 |
2020/01/22 | 2,230 | 2,313 | 2,202 | 2,304 | +91 | +4.1% | 393,900 |
2020/01/21 | 2,185 | 2,218 | 2,175 | 2,213 | +50 | +2.3% | 190,000 |
2020/01/20 | 2,109 | 2,164 | 2,107 | 2,163 | +54 | +2.6% | 121,700 |
2020/01/17 | 2,100 | 2,121 | 2,097 | 2,109 | +26 | +1.2% | 139,100 |
2020/01/16 | 2,154 | 2,155 | 2,083 | 2,083 | -49 | -2.3% | 133,400 |
2020/01/15 | 2,130 | 2,135 | 2,113 | 2,132 | -11 | -0.5% | 76,400 |
2020/01/14 | 2,174 | 2,180 | 2,083 | 2,143 | -13 | -0.6% | 163,500 |
2020/01/10 | 2,145 | 2,172 | 2,140 | 2,156 | +49 | +2.3% | 277,400 |
2020/01/09 | 2,100 | 2,131 | 2,084 | 2,107 | +80 | +3.9% | 186,100 |
2020/01/08 | 2,013 | 2,048 | 1,992 | 2,027 | -17 | -0.8% | 112,300 |
2020/01/07 | 1,995 | 2,045 | 1,994 | 2,044 | +68 | +3.4% | 141,400 |
2020/01/06 | 1,976 | 2,016 | 1,959 | 1,976 | -50 | -2.5% | 104,300 |
2019/12/30 | 2,035 | 2,052 | 2,016 | 2,026 | -9 | -0.4% | 57,200 |
2019/12/27 | 2,050 | 2,062 | 2,035 | 2,035 | -4 | -0.2% | 74,200 |
2019/12/26 | 1,983 | 2,043 | 1,983 | 2,039 | +77 | +3.9% | 132,100 |
2019/12/25 | 2,028 | 2,031 | 1,947 | 1,962 | -70 | -3.4% | 165,100 |
2019/12/24 | 2,038 | 2,053 | 2,026 | 2,032 | -6 | -0.3% | 52,700 |
2019/12/23 | 2,050 | 2,066 | 2,031 | 2,038 | -17 | -0.8% | 98,200 |
2019/12/20 | 2,043 | 2,064 | 2,019 | 2,055 | +19 | +0.9% | 109,600 |
2019/12/19 | 2,042 | 2,049 | 2,018 | 2,036 | -10 | -0.5% | 103,200 |
2019/12/18 | 2,050 | 2,069 | 2,033 | 2,046 | -1 | ±0% | 132,300 |
2019/12/17 | 2,028 | 2,047 | 1,998 | 2,047 | +34 | +1.7% | 131,100 |
2019/12/16 | 2,015 | 2,033 | 2,003 | 2,013 | -12 | -0.6% | 107,000 |
2019/12/13 | 2,033 | 2,051 | 2,010 | 2,025 | +32 | +1.6% | 199,000 |
2019/12/12 | 2,050 | 2,050 | 1,993 | 1,993 | -57 | -2.8% | 206,200 |
2019/12/11 | 2,076 | 2,078 | 2,023 | 2,050 | -17 | -0.8% | 168,500 |
2019/12/10 | 2,054 | 2,070 | 2,045 | 2,067 | +14 | +0.7% | 173,700 |
2019/12/09 | 2,050 | 2,059 | 2,032 | 2,053 | +14 | +0.7% | 139,600 |
2019/12/06 | 2,029 | 2,055 | 2,021 | 2,039 | +15 | +0.7% | 139,800 |
1151~
1200
件表示中 / 6826件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 232,200円 | +0.4% | -8.4% | 2.28% | 30.69倍 | 1.75倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,300円 | +197.7% | - | 0.00% | 49.57倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 67,900円 | -3.7% | -36.7% | 2.95% | 23.03倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 101,300円 | - | - | 0.00% | - | 51.01倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム